Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new Revision: v3.6.6 entry was added to the history, replacing Revision: v3.6.5; this reflects a small update to the page's version history rather than substantive content changes.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision entry v3.6.5 appears in the record history, updating the page version from v3.6.4 to v3.6.5. This reflects an updated metadata/version of the record without altering the study details.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page now displays Revision: v3.6.4 instead of v3.6.3, indicating a new platform version has been deployed. It appears to be a backend or UI update rather than a change to the study information.SummaryDifference0.1%

- Check65 days agoChange DetectedThe study record history shows a new revision v3.6.3 replacing the previous v3.6.2, indicating an update to the record's metadata.SummaryDifference0.1%

- Check72 days agoChange DetectedThe record history now shows revision v3.6.2, replacing the previous v3.6.0. This indicates a tracked update to the study record on the platform.SummaryDifference0.1%

- Check87 days agoChange DetectedThe study record now shows the recruitment status as No longer looking for participants, signaling that enrollment has ended. The version history includes a new Revision: v3.6.0 and removes Revision: v3.5.5, updating how the record's changes are tracked over time.SummaryDifference0.4%

Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.